Designing of CD8(+) and CD8(+)-overlapped CD4(+) epitope vaccine by targeting late and early proteins of human papillomavirus

BACKGROUND AND AIM: Human papillomavirus (HPV) is an oncogenic agent that causes over 90% of cases of cervical cancer in the world. Currently available prophylactic vaccines are type specific and have less therapeutic efficiency. Therefore, we aimed to predict the potential species-specific and ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaliamurthi, Satyavani, Selvaraj, Gurudeeban, Kaushik, Aman Chandra, Gu, Ke-Ren, Wei, Dong-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174296/
https://www.ncbi.nlm.nih.gov/pubmed/30323556
http://dx.doi.org/10.2147/BTT.S177901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174296/
https://www.ncbi.nlm.nih.gov/pubmed/30323556
http://dx.doi.org/10.2147/BTT.S177901

Ejemplares similares